ed and the prevalence of EID was 61.7%. The only independent predictor of EID was FEV 1 and the optimal cutoff value of FEV 1 was at 50% predicted (area under ROC curve, 0.85; p ! 0.001). The positive predictive value of a threshold of FEV 1 ! 50% was 0.83 with a likelihood ratio of 3.03 and the negative predicting value of a threshold of FEV 1 6 80% was 1.0. The severity of EID was correlated with daily physical activity (r = -0.31, p = 0.008). Conclusions: EID is highly prevalent among patients with COPD and can be predicted by FEV 1 . EID seems to be associated with impaired daily physical activity which supports its clinical importance.
Hypoxemia at rest is an important complication in patients with COPD [5] , potentially causing dyspnea and other deleterious effects such as pulmonary hypertension with the development of right ventricular hypertrophy, polycythemia [6] , cardiovascular disorders [7] , inflammatory cytokine production [8] and hypoxia-induced multiorgan dysfunction. Hypoxemia of less than 7.3 kPa or oxygen saturation (SpO 2 ) of less than 88% is considered an established indication for oxygen supplementation [9] [10] [11] . However, some patients do not meet these criteria during rest, but significant oxygen desaturation occurs during exertion [12] . Earlier studies have suggested that deterioration of SpO 2 during physical exercise is associated with increased risk of mortality in patients with COPD [13, 14] . Nonetheless, exercise-induced desaturation (EID) remains a topic of interest and prediction of EID could be useful for the clinical management of COPD patients to ensure maintenance of normoxemia during physical activity and elude potential adverse consequences of hypoxemia.
Clinical criteria to predict EID may help physicians caring for COPD patients to reduce the prevalence of unrecognized EID among patients with COPD without unnecessary diagnostic testing. Only a few studies addressed this topic [15-17, 19, 20] . These studies reported contradicting findings as to whether pulmonary function parameters, such as forced expiratory volume in one second (FEV 1 ) and diffusion capacity for carbon monoxide (DLCO) as well as resting SpO 2 , can predict EID. Some of these studies found that FEV 1 , DLCO and resting SpO 2 can be used as screening tests to predict EID [12, 13, 19, 20] , but others failed to identify those or other variables as predictors [5, 15, 18] .
Patients with COPD experience EID in an unpredictable fashion; patients exhibit variability in the magnitude and temporal onset of EID with ambulation, which makes it difficult to find reliable predictors as to whether patients will desaturate during exercise [17, 20] . Given the limitations and conflicting results of previous studies, the purpose of the present study was to determine the prevalence of EID, to analyze the oxygen desaturation pattern and to investigate whether FEV 1 , DLCO and resting SpO 2 are associated with EID in a large number of patients with COPD of different severity. Furthermore, we wished to investigate whether EID is associated with daily physical activity.
Methods

Study Subjects
Patients with COPD referred to the Department of Respiratory Medicine, Ruhrlandklinik, University of Duisburg-Essen, Germany between November 2008 and July 2009 and to the Pulmonary Division, University Hospital of Zurich, Switzerland between November 2009 and November 2010 were considered for participation in the study. The inclusion criteria for patients were: male/female subjects aged 40-75 years, confirmed COPD according to GOLD guidelines [1] . The exclusion criteria were: acute or recent (within last 6 weeks) exacerbation of COPD according to GOLD guidelines [1] , patients on long-term oral corticosteroids or morphine medication, mental or physical disability precluding informed consent or compliance with the protocol. The study was approved by the Research Ethics Committee of the Medical Faculty, University of Essen-Duisburg (No. 07-3524) and Zurich (No. EK-1734), and written informed consent was obtained from all patients.
Measurements
Pulmonary Function Spirometry, whole-body plethysmography and diffusion capacity measurements were performed according to the American Thoracic Society (ATS) and the European Respiratory Society guidelines with a commercially available system [21, 22] .
Six-Minute Walk Test
Patients performed the 6-min walk test (6MWT) following pulmonary function testing. 6MWT distance was measured according to the guidelines of the ATS [23] . Additionally, scored sensations of breathlessness and leg fatigue were assessed using a Borg scale [23] . Measurements of SpO 2 were performed using a finger pulse oximeter (TuffSat TM , Datex Ohmeda, Madison, Wisc., USA, and PureLight 8000, Nonin Medical Inc., Hudiksvall, Sweden). SpO 2 , dyspnea and leg fatigue were assessed after a resting period of 5 min immediately before the beginning of the 6MWT and immediately after the test. The 6MWT was performed on a 30-meter indoor track by an experienced investigator using standardized encouragement strategy [24] . None of the patients used a walking aid in daily life or during the test. EID was defined as a SpO 2 fall of 1 4 to ! 90% during the 6MWT [19, 25] . EID was calculated by the following formula: (SpO 2 at rest -SpO 2 on exertion)/SpO 2 at rest ! 100.
Oxygen Desaturation Pattern
In a subset of 43 patients recruited at the Pulmonary Division, University Hospital of Zurich, SpO 2 was continuously recorded before, during and after the 6MWT using a fingerpulse oximeter with a sample rate of 128 Hz (Nexus-10 TM , TMS International BV, Enschede, The Netherlands, and PureLight 8000, Nonin Medical Inc.) in order to describe oxygen desaturation patterns of COPD patients with GOLD stages I/II and III/IV.
Physical Activity
A multisensor armband (SenseWear Pro TM ; BodyMedia Inc., Pittsburgh, Pa., USA) monitor which is worn on the upper right arm over the triceps muscle was used to measure daily physical activity in a subset of 64 patients recruited at the Pulmonary Division, University Hospital of Zurich. It incorporates a biaxial ac-celerometer that records steps per day, physiological indicators of energy expenditure and physical activity duration. Participants were instructed to wear the accelerometer during 7 days, except when bathing or showering. The SenseWear Pro TM armband provides a valid and reliable estimate of patients' average number of steps per day/24 h [26] .
Data Analysis
A statistical software package was used for all calculations (SPSS for Windows, version 11.0; SPSS Inc., Chicago, Ill., USA). Descriptive data for continuous variables are expressed as means and standard deviation. To determine a possible correlation between EID and daily physical activity, Pearson's correlation was used. An independent t test was used for comparison of EID between patients with GOLD stages I/II and III/IV. Univariate (Pearson's correlation) and multivariate analyses were performed to assess the associations between EID and airflow limitation (FEV 1 ), diffusing capacity (DLCO) and resting SpO 2 . Other variables reflecting pathophysiologic features of COPD such as lung hyperinflation (RV/TLC), total lung capacity (TLC) and anthropometrical characteristics (BMI) were also included in the analysis. Variables which significantly correlated with EID in the univariate analysis were included in the multivariate analysis. Receiver operating characteristic (ROC) curve analysis was undertaken to determine the optimal cutoff value for predicting EID. The positive predictive value (PPV) and the negative predictive value (NPV) were calculated. To determine a possible association between EID and daily physical activity, univariate analysis (Pearson's correlation) was used. A p value of ! 0.05 was considered to be significant.
Results
Patients' Characteristics
One hundred and fifty-four patients with COPD (GOLD class I-IV) agreed to take part and were included in the study. Anthropometrical characteristics, pulmonary function, respiratory symptoms and exercise capacity data of the 154 patients (87 females) with COPD are presented in table 1 . COPD was mild (GOLD I) in 0% of the patients, moderate (GOLD II) in 7.1% of the patients, severe (GOLD III) in 26.6% of the patients and very severe (GOLD IV) in 27.9% of the patients.
Prevalence of EID and O 2 Desaturation Patterns
In total, 95 of the 154 (61.7%) patients experienced EID during the 6MWT. The prevalence of EID according to GOLD stages is shown in figure 1 . Figure 2 shows SpO 2 immediately before, during and after the 6MWT in patients with COPD in GOLD stages I/II and III/IV. SpO 2 deteriorated within the first 3 min of the 6MWT before reaching a plateau from the 4th to the 6th minute of the test. Oxygen desaturation was more pronounced in patients with GOLD stages III/IV (11.3 8 6.3%) compared to patients with GOLD stages I/II (4.2 8 4.7%) (p ! 0.001). The SpO 2 curve of patients with GOLD stages III/IV showed a steeper decline and slower recovery compared to patients with GOLD stages I/II. The SpO 2 of patients in GOLD stages I/II reached a full recovery within 1 min after the 6MWT.
Determinants of Exercise-Induced Desaturation
There was a significant positive correlation between the severity of EID and RV/TLC and TLC. A significant negative correlation was found between the severity of EID and SpO 2 at rest, FEV 1 , DLCO and BMI ( table 2 ; fig. 3 ) .
A multiple linear regression analysis which included all variables with significant correlations in the univariate analysis was performed and the results are shown in table 3 . Variables with high intercorrelations with FEV 1 (RV/TLC and TLC) were removed from the analysis. Only FEV 1 was found to be significantly and independently associated with EID. EID can be estimated with the predictive formula: EID (%) = -0.19 FEV 1 (%predict-ed) + 16.6. fig. 4 ) confirmed that the best combination of sensitivity and specificity to predict EID occurred at an FEV 1 value of 50% (area under the ROC curve 0.85; p ! 0.001).
As demonstrated in table 4 , 84 of the 95 patients with EID had a FEV 1 of less than 50% (sensitivity, 88.4%); however, 42 of 59 patients without EID had a FEV 1 of 50% or more (specificity, 71.2%). The positive predictive value of a threshold of FEV 1 ! 50% was 0.83. The likelihood ratio with FEV 1 ! 50% was 3.03. The negative predicting value for FEV 1 1 80% was 1.0. The likelihood ratio with FEV 1 1 80% was 1.14. 
Association between EID and Daily Physical Activity
Correlation analysis revealed that EID was more pronounced in patients with low daily activity as estimated by the average number of steps per day (r = -0.31, p = 0.008).
Discussion
We found a high prevalence of EID in patients with COPD during the 6MWT. The SpO 2 curve of patients with GOLD stages III/IV showed a faster decline and slower recovery compared to patients with GOLD stages I/II. It is possible to estimate the severity of EID using only FEV 1 . The positive predictive value of a threshold of FEV 1 ! 50% was 0.83 and the negative predicting value of a threshold of FEV 1 6 80% was 1.0. EID seems to have an impact on daily physical activity since we found that more severe EID was modestly associated with impaired ambulatory daily physical activity.
Hypoxemia both at rest [5] and during physical exercise [27] are important and common complications in patients with COPD. There are established criteria for prescribing oxygen therapy [10, 11] . The ATS/European Respiratory Society guidelines for the diagnosis and management of COPD recommend that oxygen therapy should be initiated if a patient's SpO 2 reaches an arterial SaO 2 of ! 88% documented at rest or during exercise [10, 11] . However, for many COPD patients long-term oxygen therapy may fall short of guideline recommendations due to undiagnosed EID.
It has been postulated that episodic hypoxemia such as EID may have adverse consequences on morbidity and mortality. EID has been reported to be associated with increased mortality in patients with COPD [13, 14] . In a study of the British Medical Research Council, patients with hypoxemia at rest receiving oxygen were compared with patients receiving no oxygen and the findings implied that oxygen therapy was associated with a significant reduction in mortality [28] . A second rationale for oxygen therapy is that dyspnea associated with EID may discourage COPD patients from exercise, promoting further deconditioning, and thus loss of pleasurable and productive activities. Acute administration of supplemental oxygen has been shown to improve ventilatory function and cardiopulmonary exercise capacity and decrease dyspnea in patients with COPD [29, 31] . In contrast, Moore et al. [30] found no improvement in dyspnea, quality of life and functional capacity after 12 weeks of oxygen therapy in COPD patients with exertional dyspnea.
The results of the present study show that the level of EID in patients with COPD deteriorates considerably with increasing severity of the disease. In this group of COPD patients, we found an unexpectedly large percent- age of patients (61.7%) who experienced EID during the 6MWT. Furthermore, we found that EID develops during the initial part (1st-4th minute) and reaches a plateau after the 4th minute during the 6MWT. The SpO 2 curve of patients with GOLD stages III/IV showed a faster decline and slower recovery compared to patients with GOLD stages I/II. This may be because patients in GOLD stages III/IV are more likely to have a reduced PaO 2 corresponding to the steeper part of the oxygen-hemoglobin dissociation curve, and thus small decreases in PaO 2 (for example during exercise) are associated with relatively large declines in SpO 2 . These results are concordant with Troosters et al. [32] , who found that VO 2 (liters/min) showed a plateau after the 3rd min of the 6MWT. The observed fast decline in SpO 2 in patients with more severe COPD may be of clinical importance as it predicts the need for chronic domiciliary oxygen therapy [33] . At this point it should be mentioned that continuous pulse oximetry is necessary to accurately describe the dynamic changes in SpO 2 during the 6MWT. Based on the large percentage of patients who experienced EID during the 6MWT in this study, it may well be that EID is a common phenomenon during activities of daily life even in patients with milder forms of COPD. Supporting this hypothesis we found that EID was associated with daily physical activity in the present study. However, this modest association needs to be interpreted with caution as the step count provided by the device used may be underestimated when patients walk slowly [34] .
Clinical criteria to predict EID may be particularly helpful to physicians working in primary care or in countries with limited resources to reduce the prevalence of unrecognized EID among patients with COPD without unnecessary diagnostic testing. A few previously published studies looked at whether pulmonary function and arterial blood gas measurements have the potential to predict the development of EID in patients with COPD [15-17, 19, 20] . Some of these studies found that FEV 1 , DLCO and resting SpO 2 can be used as screening tests to predict EID [12, 13, 19, 20] , but others failed to identify those or other variables as predictors [5, 15, 18] .
The only independent predictor of EID in the current study was FEV 1 and the optimal cutoff value of FEV 1 was at 50% (area under the ROC curve, 0.85; p ! 0.001). Owens et al. [20] found that a FEV 1 value 6 55% was 100% predictive in excluding desaturation during exercise. However, our findings imply that a considerable proportion of patients with milder forms of COPD do experience EID ( table 4 ) . On the other hand, the results of the present study confirm that there is no need for uncomplicated patients with GOLD stage I to be tested for EID. In contrast, the high positive predictive value for a threshold of FEV 1 ! 50% of 0.83 with a likelihood ratio of 3.03 underlines the importance of testing patients with COPD in GOLD stages III/IV for EID.
The present study has certain limitations that need to be taken into account. Pulse oximetry has been challenged as a poor measure of true arterial desaturation particularly during exercise [35, 36] . However, there are now several oximeters available that have features to minimize motion artifacts and provide information on the signal strength. In addition, trends of arterial oxygen desaturation during physical exercise have been proven reliable and are generally accepted as a tool for prescribing oxygen therapy [37] .
Furthermore, it should be stressed that we have not proven that oxygen supplementation in patients with COPD with EID will improve outcome. This may be particularly true in patients with mild EID and should be addressed in a randomized controlled interventional trial.
In conclusion, we found that there is a high prevalence of EID in patients with COPD and EID was associated with impaired daily physical activity. The level of EID in patients with COPD is associated with increasing severity of the disease, and it is possible to estimate exerciseinduced oxygen desaturation by using only FEV 1 . These findings may help to decide in which patients with COPD a 6MWT with continuous measurement of SpO 2 should be performed.
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